Beverly Hills Private Wealth’s AbbVie ABBV Stock Holding History

Beverly Hills Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Sell	6,164 -6,310	-51%	-$1.36M	0.3%	82
2026 Q1	$2.71M	Sell	12,474 -593	-5%	-$132K	0.45%	62
2025 Q4	$2.99M	Sell	13,067 -330	-2%	-$75.2K	0.51%	53
2025 Q3	$3.1M	Sell	13,397 -384	-3%	-$78.2K	0.55%	50
2025 Q2	$2.56M	Buy	13,781 +65	+0.5%	+$12.1K	0.48%	56
2025 Q1	$2.87M	Sell	13,716 -1,016	-7%	-$198K	0.57%	46
2024 Q4	$2.62M	Buy	14,732 +290	+2%	+$53.3K	0.53%	50
2024 Q3	$2.85M	Sell	14,442 -1,507	-9%	-$281K	0.58%	38
2024 Q2	$2.74M	Sell	15,949 -986	-6%	-$163K	0.59%	40
2024 Q1	$3.08M	Sell	16,935 -1,273	-7%	-$219K	0.71%	32
2023 Q4	$2.82M	Sell	18,208 -331	-2%	-$48.3K	0.74%	26
2023 Q3	$2.76M	Sell	18,539 -16,386	-47%	-$2.41M	0.82%	28
2023 Q2	$5.16M	Buy	34,925 +16,948	+94%	+$2.49M	0.85%	29
2023 Q1	$2.86M	Buy	17,977 +2,911	+19%	+$445K	0.89%	28
2022 Q4	$2.43M	Buy	+15,066	New	+$2.31M	1.06%	23

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Beverly Hills Private Wealth's ABBV Position: Q2 2026 in Review

Beverly Hills Private Wealth reduced its AbbVie (ABBV) stake by 51% in Q2 2026, selling an estimated $1.36M and leaving 6,164 shares worth $1.55M. The position accounts for 0.3% of the portfolio, ranked #82.

Beverly Hills Private Wealth first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.16M in Q2 2023. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Beverly Hills Private Wealth held 6,164 shares of AbbVie worth $1.55M as of Q2 2026.
Beverly Hills Private Wealth sold 6,310 AbbVie shares in Q2 2026, an estimated $1.36M.
AbbVie made up 0.3% of Beverly Hills Private Wealth's portfolio in Q2 2026, its #82 holding.
Beverly Hills Private Wealth first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Beverly Hills Private Wealth's AbbVie position peaked at $5.16M in Q2 2023.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.